{"ticker": {"uuid": "adeab8f7-07f8-47b9-b379-4892a592ac14", "symbol": "NEOG", "name": "Neogen Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neogen (NASDAQ:NEOG) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?", "summary": "Neogen (NASDAQ:NEOG) shares recently crossed above their 200-day moving average, trading as high as $9.75 against an average of $9.39. Analyst sentiment is mixed, with Wall Street Zen upgrading Neogen to a \"buy\" while Weiss Ratings reiterated a \"sell.\" Institutional ownership rem", "url": "https://www.marketbeat.com/instant-alerts/neogen-nasdaqneog-stock-price-crosses-above-200-day-moving-average-time-to-sell-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T07:20:45", "published_display": "14 Jul 2026 07:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuberger Berman discloses 7.6% stake in Neogen (NEOG) via fiduciary accounts", "summary": "Neuberger Berman Group LLC and its affiliates have reported a 7.6% beneficial ownership stake in Neogen (NEOG) as of June 30, 2026, totaling 16,570,795 shares through various fiduciary accounts. The filing emphasizes that this ownership represents aggregated client and fiduciary ", "url": "https://www.stocktitan.net/sec-filings/NEOG/schedule-13g-neogen-corp-passive-investment-disclosure-5-a0a1af8814c9.html", "source_name": "Stock Titan", "published_at": "2026-07-07T21:10:41", "published_display": "07 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Analyst Concerns Over Capital Efficiency And Equity Needs Could Impact Neogen (NEOG) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp focuses on food safety. Operations support long term growth", "summary": "Neogen Corp specializes in food and animal safety, providing testing and diagnostic solutions to manage biological risks across global supply chains. The company offers a broad range of products for detecting pathogens and contaminants in food and feed, as well as solutions for a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-focuses-on-food-safety-operations-support-long-term-growth/69681580", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T16:39:42", "published_display": "03 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NG2 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Neogen Corp (NG2) stock, including analyst price targets, future earnings, and revenue estimates. It highlights that analysts predict a maximum price of 11.42 EUR and a minimum of 9.66 EUR for NG2, and notes the company's past performance, upc", "url": "https://www.tradingview.com/symbols/FWB-NG2/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:14", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp Actuals & Estimates (NASDAQ:NEOG)", "summary": "This article provides an in-depth financial overview of Neogen Corporation (NASDAQ:NEOG), including its current stock price, historical performance, analyst forecasts, and detailed financial statements. It covers information on earnings, revenue, market capitalization, employee c", "url": "https://www.tradingview.com/symbols/NASDAQ-NEOG/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:10:14", "published_display": "26 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Gains 101.1% in a Year: What's Driving the Rally?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neogen-gains-101-1-whats-140300972.html", "source_name": "Zacks", "published_at": "2026-06-26T14:03:00+00:00", "published_display": "26 Jun 2026 14:03", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Stock Could Be 26.4% Undervalued After Texas And Florida Product Expansion", "summary": "Neogen (NEOG) is considered to be 26.4% undervalued, with a fair value of $12 against its current price of $8.83, following its expansion of FIFRA Section 2(ee) recommendations for Prozap insect control products in Texas and Florida. The company's valuation narrative is supported", "url": "https://www.sahmcapital.com/news/content/neogen-neog-stock-could-be-264-undervalued-after-texas-and-florida-product-expansion-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-24T01:10:14", "published_display": "24 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the major shareholders and institutional holdings of Neogen Corp (NEOG). It provides a breakdown of significant shareholders by proportion, types of shareholders such as investment advisors and hedge funds, and quarterly institutional shareholding data showin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/ownership", "source_name": "TradingKey", "published_at": "2026-06-22T00:10:58", "published_display": "22 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Neogen Corp (NEOG) by business segment and region, using data updated on April 6th. The \"Culture Media & Other\" segment contributes the largest proportion of revenue at 38.32%, followed by \"Bacterial & General Sanitation\" at 19.99%. R", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/revenue", "source_name": "TradingKey", "published_at": "2026-06-21T23:10:58", "published_display": "21 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen expands FIFRA 2(ee) recommendations to counter threat", "summary": "Neogen, a leader in food and animal safety solutions, has expanded the availability of FIFRA Section 2(ee) recommendations for Prozap\u00ae Insectrin X Concentrate and Prozap\u00ae Screw Worm and Ear Tick Aerosol in Texas and Florida. These recommendations provide ranchers and livestock ow", "url": "https://www.beefmagazine.com/livestock-management/neogen-expands-fifra-2-ee-recommendations-to-counter-threat", "source_name": "Beef Magazine", "published_at": "2026-06-18T22:40:27", "published_display": "18 Jun 2026 22:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen\u00ae Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neogen-committed-helping-ranchers-livestock-124500879.html", "source_name": "Business Wire", "published_at": "2026-06-18T12:45:00+00:00", "published_display": "18 Jun 2026 12:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen adds Texas, Florida fly-control tools for New World screwworm", "summary": "Neogen Corporation has expanded the availability of its FIFRA Section 2(ee) recommendations for Prozap\u00ae Insectrin X Concentrate and Prozap\u00ae Screw Worm and Ear Tick Aerosol in Texas and Florida. These products will help ranchers, livestock producers, and horse owners combat the Ne", "url": "https://www.stocktitan.net/news/NEOG/neogen-committed-to-helping-ranchers-livestock-producers-and-horse-08m1nrcir63w.html", "source_name": "Stock Titan", "published_at": "2026-06-18T13:09:00", "published_display": "18 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Expanded Prozap Use in Texas and Florida Signal a Deeper Shift in Neogen's (NEOG) Animal Health Strategy?", "summary": "Neogen Corporation has expanded the availability of its Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol in Texas and Florida, offering more options for livestock and horse owners in pest management. This move, while incremental, supports Neogen's Animal ", "url": "https://www.sahmcapital.com/news/content/does-expanded-prozap-use-in-texas-and-florida-signal-a-deeper-shift-in-neogens-neog-animal-health-strategy-2026-06-18", "source_name": "Sahm", "published_at": "2026-06-18T10:39:41", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief valuation analysis for Neogen Corp (NEOG), stating its current valuation score and its ranking within the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio and notes that P/B, P/S, and P/CF data have not yet been", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T22:09:00", "published_display": "17 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "Neogen Corp (NEOG) currently shows a risk assessment score of 5.27, placing it 83rd out of 204 in the Healthcare Equipment & Supplies industry. The stock's beta of 1.82 indicates higher volatility compared to the S&P 500. Key metrics include a 240-day maximum drawdown of +27.71% ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:40:29", "published_display": "17 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Neogen Corp (NEOG) currently holds an earnings forecast score of 7.50, ranking 135th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $7.25, with a majority recommending a \"Buy\" trend. The company's expected revenue for the next quarte", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T17:40:16", "published_display": "17 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Institutional Confidence", "summary": "Neogen Corp (NEOG) has a strong institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional holdings increased by 6.66% quarter-over-quarter, with Ron Baron being the largest shareholder. Major institutional investors", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T09:40:29", "published_display": "16 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neogen Corp Stock (US6404911066): Quiet Day, Stock in Focus at Monday's Close", "summary": "Neogen Corp shares were in focus on June 15, 2026, but without any verified new market triggers, analyst updates, earnings releases, or sector catalysts. The stock is identified as a \"quiet-day name\" driven by the company's operating story and prior disclosures, rather than new h", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-quiet-day-stock-in-focus-at-monday-s/69546878", "source_name": "AD HOC NEWS", "published_at": "2026-06-15T18:39:58", "published_display": "15 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen updates Igenity Beef with new traits", "summary": "Neogen's genomics division has updated its Igenity Beef genomic profile, specifically for commercial cow-calf producers. The new features include a BRD (Bovine Respiratory Disease) score, a Sustainability Index with Sustainability Extra Dollars, and a Methane Emission Intensity I", "url": "https://www.beefmagazine.com/livestock-management/neogen-updates-igenity-beef-with-new-traits", "source_name": "Beef Magazine", "published_at": "2026-06-10T22:41:00", "published_display": "10 Jun 2026 22:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEOGEN (NEOG) CAO has shares withheld to cover RSU tax obligations", "summary": "NEOGEN's Chief Accounting Officer, John Patrick Moylan, had 2,553 shares withheld to cover tax obligations related to the vesting of restricted stock units (RSUs) on June 3, 2026. This transaction, valued at $8.75 per share, was a non-market disposition for tax withholding purpos", "url": "https://www.stocktitan.net/sec-filings/NEOG/form-4-neogen-corp-insider-trading-activity-b84fcdee5d1e.html", "source_name": "Stock Titan", "published_at": "2026-06-04T13:10:00", "published_display": "04 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Neogen (NEOG) Petrifilm Shift and Operational Efficiency Push", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-reacting-neogen-neog-petrifilm-061120715.html", "source_name": "Simply Wall St.", "published_at": "2026-06-04T06:11:20+00:00", "published_display": "04 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amy M. Rocklin sells 87,681 NEOG shares (NASDAQ:NEOG)", "summary": "Amy M. Rocklin reported the sale of 87,681 shares of NEOGEN CORP (NASDAQ:NEOG) common stock on May 29, 2026, generating proceeds of $805,153.08. This transaction was disclosed via a Form 144 SEC filing, which records affiliate sales, and also notes an option granted date of June ", "url": "https://www.stocktitan.net/sec-filings/NEOG/144-neogen-corp-sec-filing-f0eb2084a7aa.html", "source_name": "Stock Titan", "published_at": "2026-06-03T19:09:10", "published_display": "03 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Q3 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/9a8a160d-f7d0-320e-982f-1cdc7ccd3c13/neogen-%28neog%29-q3-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T15:48:52+00:00", "published_display": "02 Jun 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEOG - Neogen Corp Stock Price and Quote", "summary": "This article provides a detailed financial overview of Neogen Corp (NEOG), including its stock performance, key financial metrics, analyst ratings, and recent news. It highlights the company's valuation, insider transactions, and upcoming earnings reports, offering a comprehensiv", "url": "https://finviz.com/stock?t=NEOG", "source_name": "Finviz", "published_at": "2026-06-02T16:09:58", "published_display": "02 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Neogen (NEOG) Valuation After Earnings Beat But Slower Growth Than Peers", "summary": "Neogen (NEOG) reported earnings and revenue that exceeded analyst estimates, but its revenue declined 4.4% year-on-year and lagged behind peers. Despite this, the stock is considered 22.5% undervalued with a narrative fair value of $12.00, driven by portfolio simplification, a fo", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-neog/neogen/news/assessing-neogen-neog-valuation-after-earnings-beat-but-slow", "source_name": "Simply Wall Street", "published_at": "2026-05-30T15:09:51", "published_display": "30 May 2026 15:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] NEOGEN CORP SEC Filing", "summary": "This article reports on a Form 144 SEC filing by NEOGEN CORP (NEOG) for a proposed sale of securities. The filing indicates a sale of 87,681 shares of common stock with an aggregate market value of $805,153.69, acquired via stock option grant on August 15, 2025, and scheduled for", "url": "https://www.stocktitan.net/sec-filings/NEOG/144-neogen-corp-sec-filing-a1890317014d.html", "source_name": "Stock Titan", "published_at": "2026-05-29T18:09:42", "published_display": "29 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): share jumps after strong quarterly update and integration progress", "summary": "Neogen Corp's stock experienced a jump following a strong quarterly report that highlighted solid growth in food safety testing and significant progress in integrating the acquired 3M food safety business. The company's focus on food safety solutions and animal health products, a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-share-jumps-after-strong-quarterly/69392192", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T14:12:15", "published_display": "21 May 2026 14:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neogen (NEOG) officer exercises 35,183 shares, settles tax with stock", "summary": "Former Chief Legal Officer of Neogen (NEOG), Amy M. Rocklin, exercised 35,183 Restricted Stock Units, converting them into common stock at $9.29 per share. To cover tax obligations, 10,241 shares were withheld. Following these transactions, Rocklin directly holds 82,182 shares of", "url": "https://www.stocktitan.net/sec-filings/NEOG/form-4-neogen-corp-insider-trading-activity-e20935bded97.html", "source_name": "Stock Titan", "published_at": "2026-05-19T12:09:27", "published_display": "19 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): integration progress and growth drivers in food and animal safety", "summary": "Neogen Corp (NEOG) is actively integrating its acquired 3M food safety business, a process that brings both costs and revenue synergies. The company's core business revolves around food and animal safety diagnostics, with major revenue drivers including diagnostic kits, genomics ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-integration-progress-and-growth-drivers/69353784", "source_name": "AD HOC NEWS", "published_at": "2026-05-17T07:09:24", "published_display": "17 May 2026 07:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): what rising short interest means for investors", "summary": "Neogen Corp (NEOG) shares have seen increased short interest, reaching over 5% of its free float, as the company continues to integrate its 3M acquisition and expand its product portfolio on Nasdaq. The company, a specialist in food and animal safety diagnostics, faces challenges", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-what-rising-short-interest-means-for/69351371", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T17:40:24", "published_display": "16 May 2026 17:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarkston Capital Group discloses 2.2M shares of Neogen (NEOG)", "summary": "Clarkston Capital Group, along with Clarkston Capital Partners, LLC, Clarkston Companies, Inc., Jeffrey A. Hakala, and Gerald W. Hakala, has disclosed beneficial ownership of 2,204,788 shares of Neogen Corporation (NEOG). This represents a 1.01% stake in the company, based on 217", "url": "https://www.stocktitan.net/sec-filings/NEOG/schedule-13g-a-neogen-corp-amended-passive-investment-disclosure-2358e19cde63.html", "source_name": "Stock Titan", "published_at": "2026-05-14T18:09:15", "published_display": "14 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): Recent 1.95% gain amid volatility", "summary": "Neogen Corp (NEOG) shares recently gained 1.95% to $5.22 on July 25, 2025, extending a five-day winning streak despite a prior two-week loss, with analysts monitoring upcoming earnings on July 29, 2025. The company specializes in diagnostic test kits for food safety and animal he", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-recent-1-95-percent-gain-amid/69332875", "source_name": "AD HOC NEWS", "published_at": "2026-05-14T11:09:15", "published_display": "14 May 2026 11:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Zen Upgrades Neogen (NASDAQ:NEOG) to \"Buy\"", "summary": "Wall Street Zen upgraded Neogen (NASDAQ:NEOG) to a \"buy\" rating from \"hold\" on Saturday. The upgrade comes after Neogen reported stronger-than-expected quarterly results, with EPS of $0.09 against estimates of $0.04 and revenue of $211.2 million, surpassing forecasts despite a 4.", "url": "https://www.marketbeat.com/instant-alerts/wall-street-zen-upgrades-neogen-nasdaqneog-to-buy-2026-05-09/", "source_name": "MarketBeat", "published_at": "2026-05-10T05:39:11", "published_display": "10 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Neogen\u2019s New Executive Equity Grants Reveal a Deeper Strategic Shift at NEOG?", "summary": "Neogen's Chief Legal Officer recently received substantial equity grants, coinciding with the company facing declining sales, shrinking returns on capital, and ongoing EBITDA losses. While these grants don't immediately alter the investment narrative, they highlight the company's", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-neog/neogen/news/do-neogens-new-executive-equity-grants-reveal-a-deeper-strat", "source_name": "Simply Wall Street", "published_at": "2026-05-06T20:39:52", "published_display": "06 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Weaker Sales And Returns Reshaping The Investment Case For Neogen\u2019s (NEOG) Valuation Assumptions?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVExHb2c3LUNXdkdUMC1wdElCTVY1bmJGcW9MZ2NaMU9WdVMtUUFXQjlSYWpzdUt3NkgwLW95NlljeGpWUklrT3pkNy0yelJzZEpYZnpqemNzeXJHVzV3WW4wRW5lN3hxbDRGanFYYXU4bkh6WWhJQ2I4MmNOMlVqQkF6UW93UXYwaFc2aEZBaGhkdUdzRjFuQzYwczdVVlA2UGI0N2M0bm5wQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neogen and Baxter Shares Are Falling, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPSmhVMTA2a2FkcmN6bklYNFo5MjlCQ1dFdF85WmZvRVhpWUVmbHRNdGlZbkFLM0lUWW9wMkNGV0xYT1BwQ2dGVVZGcUZUUHFIb2ZyOHFUZWZ2V29FNmZqVXBXSk9Camk0V0hHa29oM2piei1KTjUxQVFlRl9PdTFIam8tRnRoWjBrcUpXMzYwNFd3R1lOZk5VWS00NWdwclNiTVV6UG1Db1NkNkxkcDFFbFNnbnVxLXVNbFFjSA?oc=5", "source_name": "StockStory", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "5 Must-Read Analyst Questions From Neogen\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPM3pKY3M3LWJjWV9YUm1QMnU4SElmUnVpOVVvYmlGT1dXWHZoZ3JMN2l4eG5meEMtVHZxM20xYlZHM0ZKYS1rUEV3UnNQaHlSSEh6SXo2LXhNWFIxTXVLYUkyMVRTdGgyZl9DcDd3dHU4RzJOa2kycHpjS2xDVWxmaW1ZT3ZoVVRDU194X0JlXzA3REtJaTlSVm93?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYWViNFpVckhPMjZPZ0ZueGRTcTlkak0yQ3d0VU9fdWhGVnEzbG9WZ3d5bTVBaTlTeEt4S3JnU2hMM0EtMnAxN3VLYk91M2hieUtpdGx0bWtwb3NWMnVJVExHcnBmWmdOSUVWOHZjdC1ZMk12X1RoMWc5ZGNQaF9faklDSG50cUxPV0tWck5RM0FuREdaUTI0eE9MZURDMDBTSllGRHpkN1I?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWTduWG9lSDNPWDRzNVNvQThWN1YxZzRDYTQzZUhnajctczhyN2NwOWpkT1NPTmp0MTA5M2g5b3Z4SGNyMFZ6eGFRcG9tVU1sTjJmbUNzR1dEc0VJVS1nek1MVnBfM2VuM1gwdGtNMS02cW0yVEpxdExJVHc4QWVtcjlUQ09WNl9EcDdtaEdXZVZrZWdjNHBR?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Reshapes Portfolio Around Food Safety With Divestitures And Job Cuts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Q3 Losses Keep Margin Concerns Central To Bullish Discount Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Neogen beats Q3 2026 forecasts but stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOXzR1cUdFSFR1ZHkwNHN2NFpRRFg1T2pUUHhDVlZDOXk5dk55anBjbkFQSFNQRGxVald4XzhZWlhrU2JrSTNkVHdkeWxqeFRKOFo2cU9mLTdxZTJMZ1J1Y3RLaDBuMlRjTnRBYlNNaWhrRG5iNGdwTUVNMUN4Q0IwODI0MmN3WWZKNmRZZGdlWlF6d1hEajI5Yk9PSXJKQV9lbUQtNGVoNkl4WE4tNDR0bm0yOW9SeDBvRHBqQVFfem0ySkVG?oc=5", "source_name": "Investing.com", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Neogen (NEOG) Now Offering Value After Its Strong Year To Date Share Price Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNem5ONVhUQUVLUzJCZUJJMzdKQkVJSzM4SmtmbE9IVi1kWk82YTRYa3FvdlhiLVVWdHlpQkFxaFF0SjU0dFhPZTlZd2RmY0U5cF9zWENQRWFucDI1V1dkQkt0cnNRZHhnTllPdjNZMTVJLWRKLVE3MWVnRDFFQTktMVlzaGJIR0R0cXNmZFJ4SW1Bby1aZXBncmk5MA?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Countdown to Neogen (NEOG) Q3 Earnings: Wall Street Forecasts for Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONWFqT195Z2hlYlMtcHVQMXQyRVlGcEZPT2FyVkI2dlkwMlJYS0RBN1NfVk1OZzlCOThfZnJJWGZPdmJUYTVycWdkSmxwcG1SZzd2YVkzSWVCcDdhcjZXSi1MUWZoMXRnbEFDUlVFbWxWUlBvZ3lKY1psZ1Q4cWhaSXlCZzZSbFpqci1pNmlBVDMyeWJXaGlWQnhkd0RwWms?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPWmJzLW8xX1VPTE02d1d2bnRTR3JDd29OQzR3a3RtSGExcFdSOVZhRS1SZWZBVThLR2RTTFRaMkhQU1Y2bEc0NHRmSk1ENDdoaWNXNmtRTVhyUVZLU09uZ3E0dGZ6TC1uUnFjeWg1cVZkazVNcTFGQ0QzRkVKbzZLc2EwTGR1RzlGM1k2VFpmVERYb3Y4NDZaMU9rNDU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Neogen Labor Rally Sparks Investor Uncertainty In Michigan", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSFRacHNGRndPYXFUMGlPbzdxbzh1R3hYcnJqVnBNMGtRaE5IUDNUd2ZWa3ZHWUtMdzFuRG1ab0lRVkh0X3ZuWHpSZE5lb01acU9NcFdQU0w2WTBJN3ZRTmVzZFpqcVI4bmg1SVhtRXdJQ2tVMk0ydm1DY2MtOGhobFUyY2tIcWM4YWJOSHc0ei1odFRiZDNN?oc=5", "source_name": "Evrim A\u011fac\u0131", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zoetis to acquire animal genomics business from Neogen", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPSC1OckJCdXpBclZwcGlDeTRtQVRGUDNuNEtPdk1ob2FQTnFoTkVndi1kdWFvdlZxOHdaOFRkb0djQkVYNW9BSGtaMzBGX21xT0tiWkJ3T0dOT2J1NVpqc2U5TmlxZmtJV2hPZTh5UkR6TmRnSnd3c0RDVkJwczdWUUQ5YzRseDVyWUh6Zkl1ekhmV1otTTNkZ0tMVERjbUJxQmxPWWRB?oc=5", "source_name": "Pet Food Processing", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zoetis stock slips despite deal for Neogen genomics unit, BofA and Leerink React", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQOWRrNDdmcUFKcTYxT19OaGU0cHRlU09sT0hqUGloQThoZ1I3Rnp2eDE0NU5aNlFiUzlrMEhqZzVlbFVNcmxhblNzWEo2N2dFOUVHcHlkV21kc2JGUkFzOWFHYkl3UjR5c2NieDRCVTdEQkcyamNFM1p6VUpBUUdOcC0weEwwMW9QQTJFTEpUem1FQXBJZGR4ZmtVVkJzSi0xTFl3NlJTT3lMcnZaQUhFMTljR05DSkNLalpYSzNYbkpaYlJSN3FmQlZ6dXd0ZTdBUENoS0t4cEc?oc=5", "source_name": "Investing.com", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Neogen (NASDAQ:NEOG) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?", "summary": "Neogen (NASDAQ:NEOG) shares recently crossed above their 200-day moving average, trading as high as $9.75 against an average of $9.39. Analyst sentiment is mixed, with Wall Street Zen upgrading Neogen to a \"buy\" while Weiss Ratings reiterated a \"sell.\" Institutional ownership rem", "url": "https://www.marketbeat.com/instant-alerts/neogen-nasdaqneog-stock-price-crosses-above-200-day-moving-average-time-to-sell-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T07:20:45", "published_display": "14 Jul 2026 07:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neuberger Berman discloses 7.6% stake in Neogen (NEOG) via fiduciary accounts", "summary": "Neuberger Berman Group LLC and its affiliates have reported a 7.6% beneficial ownership stake in Neogen (NEOG) as of June 30, 2026, totaling 16,570,795 shares through various fiduciary accounts. The filing emphasizes that this ownership represents aggregated client and fiduciary ", "url": "https://www.stocktitan.net/sec-filings/NEOG/schedule-13g-neogen-corp-passive-investment-disclosure-5-a0a1af8814c9.html", "source_name": "Stock Titan", "published_at": "2026-07-07T21:10:41", "published_display": "07 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Analyst Concerns Over Capital Efficiency And Equity Needs Could Impact Neogen (NEOG) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp focuses on food safety. Operations support long term growth", "summary": "Neogen Corp specializes in food and animal safety, providing testing and diagnostic solutions to manage biological risks across global supply chains. The company offers a broad range of products for detecting pathogens and contaminants in food and feed, as well as solutions for a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-focuses-on-food-safety-operations-support-long-term-growth/69681580", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T16:39:42", "published_display": "03 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NG2 Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Neogen Corp (NG2) stock, including analyst price targets, future earnings, and revenue estimates. It highlights that analysts predict a maximum price of 11.42 EUR and a minimum of 9.66 EUR for NG2, and notes the company's past performance, upc", "url": "https://www.tradingview.com/symbols/FWB-NG2/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:14", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp Actuals & Estimates (NASDAQ:NEOG)", "summary": "This article provides an in-depth financial overview of Neogen Corporation (NASDAQ:NEOG), including its current stock price, historical performance, analyst forecasts, and detailed financial statements. It covers information on earnings, revenue, market capitalization, employee c", "url": "https://www.tradingview.com/symbols/NASDAQ-NEOG/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:10:14", "published_display": "26 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Gains 101.1% in a Year: What's Driving the Rally?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neogen-gains-101-1-whats-140300972.html", "source_name": "Zacks", "published_at": "2026-06-26T14:03:00+00:00", "published_display": "26 Jun 2026 14:03", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Stock Could Be 26.4% Undervalued After Texas And Florida Product Expansion", "summary": "Neogen (NEOG) is considered to be 26.4% undervalued, with a fair value of $12 against its current price of $8.83, following its expansion of FIFRA Section 2(ee) recommendations for Prozap insect control products in Texas and Florida. The company's valuation narrative is supported", "url": "https://www.sahmcapital.com/news/content/neogen-neog-stock-could-be-264-undervalued-after-texas-and-florida-product-expansion-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-24T01:10:14", "published_display": "24 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the major shareholders and institutional holdings of Neogen Corp (NEOG). It provides a breakdown of significant shareholders by proportion, types of shareholders such as investment advisors and hedge funds, and quarterly institutional shareholding data showin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/ownership", "source_name": "TradingKey", "published_at": "2026-06-22T00:10:58", "published_display": "22 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Neogen Corp (NEOG) by business segment and region, using data updated on April 6th. The \"Culture Media & Other\" segment contributes the largest proportion of revenue at 38.32%, followed by \"Bacterial & General Sanitation\" at 19.99%. R", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/revenue", "source_name": "TradingKey", "published_at": "2026-06-21T23:10:58", "published_display": "21 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen expands FIFRA 2(ee) recommendations to counter threat", "summary": "Neogen, a leader in food and animal safety solutions, has expanded the availability of FIFRA Section 2(ee) recommendations for Prozap\u00ae Insectrin X Concentrate and Prozap\u00ae Screw Worm and Ear Tick Aerosol in Texas and Florida. These recommendations provide ranchers and livestock ow", "url": "https://www.beefmagazine.com/livestock-management/neogen-expands-fifra-2-ee-recommendations-to-counter-threat", "source_name": "Beef Magazine", "published_at": "2026-06-18T22:40:27", "published_display": "18 Jun 2026 22:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen\u00ae Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/neogen-committed-helping-ranchers-livestock-124500879.html", "source_name": "Business Wire", "published_at": "2026-06-18T12:45:00+00:00", "published_display": "18 Jun 2026 12:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen adds Texas, Florida fly-control tools for New World screwworm", "summary": "Neogen Corporation has expanded the availability of its FIFRA Section 2(ee) recommendations for Prozap\u00ae Insectrin X Concentrate and Prozap\u00ae Screw Worm and Ear Tick Aerosol in Texas and Florida. These products will help ranchers, livestock producers, and horse owners combat the Ne", "url": "https://www.stocktitan.net/news/NEOG/neogen-committed-to-helping-ranchers-livestock-producers-and-horse-08m1nrcir63w.html", "source_name": "Stock Titan", "published_at": "2026-06-18T13:09:00", "published_display": "18 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Expanded Prozap Use in Texas and Florida Signal a Deeper Shift in Neogen's (NEOG) Animal Health Strategy?", "summary": "Neogen Corporation has expanded the availability of its Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol in Texas and Florida, offering more options for livestock and horse owners in pest management. This move, while incremental, supports Neogen's Animal ", "url": "https://www.sahmcapital.com/news/content/does-expanded-prozap-use-in-texas-and-florida-signal-a-deeper-shift-in-neogens-neog-animal-health-strategy-2026-06-18", "source_name": "Sahm", "published_at": "2026-06-18T10:39:41", "published_display": "18 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief valuation analysis for Neogen Corp (NEOG), stating its current valuation score and its ranking within the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio and notes that P/B, P/S, and P/CF data have not yet been", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T22:09:00", "published_display": "17 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "Neogen Corp (NEOG) currently shows a risk assessment score of 5.27, placing it 83rd out of 204 in the Healthcare Equipment & Supplies industry. The stock's beta of 1.82 indicates higher volatility compared to the S&P 500. Key metrics include a 240-day maximum drawdown of +27.71% ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-17T21:40:29", "published_display": "17 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Neogen Corp (NEOG) currently holds an earnings forecast score of 7.50, ranking 135th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $7.25, with a majority recommending a \"Buy\" trend. The company's expected revenue for the next quarte", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T17:40:16", "published_display": "17 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp (NEOG) Institutional Confidence", "summary": "Neogen Corp (NEOG) has a strong institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional holdings increased by 6.66% quarter-over-quarter, with Ron Baron being the largest shareholder. Major institutional investors", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neog/sentiment", "source_name": "TradingKey", "published_at": "2026-06-16T09:40:29", "published_display": "16 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp Stock (US6404911066): Quiet Day, Stock in Focus at Monday's Close", "summary": "Neogen Corp shares were in focus on June 15, 2026, but without any verified new market triggers, analyst updates, earnings releases, or sector catalysts. The stock is identified as a \"quiet-day name\" driven by the company's operating story and prior disclosures, rather than new h", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-quiet-day-stock-in-focus-at-monday-s/69546878", "source_name": "AD HOC NEWS", "published_at": "2026-06-15T18:39:58", "published_display": "15 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen updates Igenity Beef with new traits", "summary": "Neogen's genomics division has updated its Igenity Beef genomic profile, specifically for commercial cow-calf producers. The new features include a BRD (Bovine Respiratory Disease) score, a Sustainability Index with Sustainability Extra Dollars, and a Methane Emission Intensity I", "url": "https://www.beefmagazine.com/livestock-management/neogen-updates-igenity-beef-with-new-traits", "source_name": "Beef Magazine", "published_at": "2026-06-10T22:41:00", "published_display": "10 Jun 2026 22:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEOGEN (NEOG) CAO has shares withheld to cover RSU tax obligations", "summary": "NEOGEN's Chief Accounting Officer, John Patrick Moylan, had 2,553 shares withheld to cover tax obligations related to the vesting of restricted stock units (RSUs) on June 3, 2026. This transaction, valued at $8.75 per share, was a non-market disposition for tax withholding purpos", "url": "https://www.stocktitan.net/sec-filings/NEOG/form-4-neogen-corp-insider-trading-activity-b84fcdee5d1e.html", "source_name": "Stock Titan", "published_at": "2026-06-04T13:10:00", "published_display": "04 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Neogen (NEOG) Petrifilm Shift and Operational Efficiency Push", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-reacting-neogen-neog-petrifilm-061120715.html", "source_name": "Simply Wall St.", "published_at": "2026-06-04T06:11:20+00:00", "published_display": "04 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Amy M. Rocklin sells 87,681 NEOG shares (NASDAQ:NEOG)", "summary": "Amy M. Rocklin reported the sale of 87,681 shares of NEOGEN CORP (NASDAQ:NEOG) common stock on May 29, 2026, generating proceeds of $805,153.08. This transaction was disclosed via a Form 144 SEC filing, which records affiliate sales, and also notes an option granted date of June ", "url": "https://www.stocktitan.net/sec-filings/NEOG/144-neogen-corp-sec-filing-f0eb2084a7aa.html", "source_name": "Stock Titan", "published_at": "2026-06-03T19:09:10", "published_display": "03 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Q3 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/9a8a160d-f7d0-320e-982f-1cdc7ccd3c13/neogen-%28neog%29-q3-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-02T15:48:52+00:00", "published_display": "02 Jun 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEOG - Neogen Corp Stock Price and Quote", "summary": "This article provides a detailed financial overview of Neogen Corp (NEOG), including its stock performance, key financial metrics, analyst ratings, and recent news. It highlights the company's valuation, insider transactions, and upcoming earnings reports, offering a comprehensiv", "url": "https://finviz.com/stock?t=NEOG", "source_name": "Finviz", "published_at": "2026-06-02T16:09:58", "published_display": "02 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Neogen (NEOG) Valuation After Earnings Beat But Slower Growth Than Peers", "summary": "Neogen (NEOG) reported earnings and revenue that exceeded analyst estimates, but its revenue declined 4.4% year-on-year and lagged behind peers. Despite this, the stock is considered 22.5% undervalued with a narrative fair value of $12.00, driven by portfolio simplification, a fo", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-neog/neogen/news/assessing-neogen-neog-valuation-after-earnings-beat-but-slow", "source_name": "Simply Wall Street", "published_at": "2026-05-30T15:09:51", "published_display": "30 May 2026 15:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] NEOGEN CORP SEC Filing", "summary": "This article reports on a Form 144 SEC filing by NEOGEN CORP (NEOG) for a proposed sale of securities. The filing indicates a sale of 87,681 shares of common stock with an aggregate market value of $805,153.69, acquired via stock option grant on August 15, 2025, and scheduled for", "url": "https://www.stocktitan.net/sec-filings/NEOG/144-neogen-corp-sec-filing-a1890317014d.html", "source_name": "Stock Titan", "published_at": "2026-05-29T18:09:42", "published_display": "29 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): share jumps after strong quarterly update and integration progress", "summary": "Neogen Corp's stock experienced a jump following a strong quarterly report that highlighted solid growth in food safety testing and significant progress in integrating the acquired 3M food safety business. The company's focus on food safety solutions and animal health products, a", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-share-jumps-after-strong-quarterly/69392192", "source_name": "AD HOC NEWS", "published_at": "2026-05-21T14:12:15", "published_display": "21 May 2026 14:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) officer exercises 35,183 shares, settles tax with stock", "summary": "Former Chief Legal Officer of Neogen (NEOG), Amy M. Rocklin, exercised 35,183 Restricted Stock Units, converting them into common stock at $9.29 per share. To cover tax obligations, 10,241 shares were withheld. Following these transactions, Rocklin directly holds 82,182 shares of", "url": "https://www.stocktitan.net/sec-filings/NEOG/form-4-neogen-corp-insider-trading-activity-e20935bded97.html", "source_name": "Stock Titan", "published_at": "2026-05-19T12:09:27", "published_display": "19 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): integration progress and growth drivers in food and animal safety", "summary": "Neogen Corp (NEOG) is actively integrating its acquired 3M food safety business, a process that brings both costs and revenue synergies. The company's core business revolves around food and animal safety diagnostics, with major revenue drivers including diagnostic kits, genomics ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-integration-progress-and-growth-drivers/69353784", "source_name": "AD HOC NEWS", "published_at": "2026-05-17T07:09:24", "published_display": "17 May 2026 07:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): what rising short interest means for investors", "summary": "Neogen Corp (NEOG) shares have seen increased short interest, reaching over 5% of its free float, as the company continues to integrate its 3M acquisition and expand its product portfolio on Nasdaq. The company, a specialist in food and animal safety diagnostics, faces challenges", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-what-rising-short-interest-means-for/69351371", "source_name": "AD HOC NEWS", "published_at": "2026-05-16T17:40:24", "published_display": "16 May 2026 17:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clarkston Capital Group discloses 2.2M shares of Neogen (NEOG)", "summary": "Clarkston Capital Group, along with Clarkston Capital Partners, LLC, Clarkston Companies, Inc., Jeffrey A. Hakala, and Gerald W. Hakala, has disclosed beneficial ownership of 2,204,788 shares of Neogen Corporation (NEOG). This represents a 1.01% stake in the company, based on 217", "url": "https://www.stocktitan.net/sec-filings/NEOG/schedule-13g-a-neogen-corp-amended-passive-investment-disclosure-2358e19cde63.html", "source_name": "Stock Titan", "published_at": "2026-05-14T18:09:15", "published_display": "14 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Corp stock (US6404911066): Recent 1.95% gain amid volatility", "summary": "Neogen Corp (NEOG) shares recently gained 1.95% to $5.22 on July 25, 2025, extending a five-day winning streak despite a prior two-week loss, with analysts monitoring upcoming earnings on July 29, 2025. The company specializes in diagnostic test kits for food safety and animal he", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/neogen-corp-stock-us6404911066-recent-1-95-percent-gain-amid/69332875", "source_name": "AD HOC NEWS", "published_at": "2026-05-14T11:09:15", "published_display": "14 May 2026 11:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Zen Upgrades Neogen (NASDAQ:NEOG) to \"Buy\"", "summary": "Wall Street Zen upgraded Neogen (NASDAQ:NEOG) to a \"buy\" rating from \"hold\" on Saturday. The upgrade comes after Neogen reported stronger-than-expected quarterly results, with EPS of $0.09 against estimates of $0.04 and revenue of $211.2 million, surpassing forecasts despite a 4.", "url": "https://www.marketbeat.com/instant-alerts/wall-street-zen-upgrades-neogen-nasdaqneog-to-buy-2026-05-09/", "source_name": "MarketBeat", "published_at": "2026-05-10T05:39:11", "published_display": "10 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Neogen\u2019s New Executive Equity Grants Reveal a Deeper Strategic Shift at NEOG?", "summary": "Neogen's Chief Legal Officer recently received substantial equity grants, coinciding with the company facing declining sales, shrinking returns on capital, and ongoing EBITDA losses. While these grants don't immediately alter the investment narrative, they highlight the company's", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-neog/neogen/news/do-neogens-new-executive-equity-grants-reveal-a-deeper-strat", "source_name": "Simply Wall Street", "published_at": "2026-05-06T20:39:52", "published_display": "06 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Weaker Sales And Returns Reshaping The Investment Case For Neogen\u2019s (NEOG) Valuation Assumptions?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVExHb2c3LUNXdkdUMC1wdElCTVY1bmJGcW9MZ2NaMU9WdVMtUUFXQjlSYWpzdUt3NkgwLW95NlljeGpWUklrT3pkNy0yelJzZEpYZnpqemNzeXJHVzV3WW4wRW5lN3hxbDRGanFYYXU4bkh6WWhJQ2I4MmNOMlVqQkF6UW93UXYwaFc2aEZBaGhkdUdzRjFuQzYwczdVVlA2UGI0N2M0bm5wQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen and Baxter Shares Are Falling, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPSmhVMTA2a2FkcmN6bklYNFo5MjlCQ1dFdF85WmZvRVhpWUVmbHRNdGlZbkFLM0lUWW9wMkNGV0xYT1BwQ2dGVVZGcUZUUHFIb2ZyOHFUZWZ2V29FNmZqVXBXSk9Camk0V0hHa29oM2piei1KTjUxQVFlRl9PdTFIam8tRnRoWjBrcUpXMzYwNFd3R1lOZk5VWS00NWdwclNiTVV6UG1Db1NkNkxkcDFFbFNnbnVxLXVNbFFjSA?oc=5", "source_name": "StockStory", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Must-Read Analyst Questions From Neogen\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPM3pKY3M3LWJjWV9YUm1QMnU4SElmUnVpOVVvYmlGT1dXWHZoZ3JMN2l4eG5meEMtVHZxM20xYlZHM0ZKYS1rUEV3UnNQaHlSSEh6SXo2LXhNWFIxTXVLYUkyMVRTdGgyZl9DcDd3dHU4RzJOa2kycHpjS2xDVWxmaW1ZT3ZoVVRDU194X0JlXzA3REtJaTlSVm93?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYWViNFpVckhPMjZPZ0ZueGRTcTlkak0yQ3d0VU9fdWhGVnEzbG9WZ3d5bTVBaTlTeEt4S3JnU2hMM0EtMnAxN3VLYk91M2hieUtpdGx0bWtwb3NWMnVJVExHcnBmWmdOSUVWOHZjdC1ZMk12X1RoMWc5ZGNQaF9faklDSG50cUxPV0tWck5RM0FuREdaUTI0eE9MZURDMDBTSllGRHpkN1I?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWTduWG9lSDNPWDRzNVNvQThWN1YxZzRDYTQzZUhnajctczhyN2NwOWpkT1NPTmp0MTA5M2g5b3Z4SGNyMFZ6eGFRcG9tVU1sTjJmbUNzR1dEc0VJVS1nek1MVnBfM2VuM1gwdGtNMS02cW0yVEpxdExJVHc4QWVtcjlUQ09WNl9EcDdtaEdXZVZrZWdjNHBR?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Reshapes Portfolio Around Food Safety With Divestitures And Job Cuts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen (NEOG) Q3 Losses Keep Margin Concerns Central To Bullish Discount Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Neogen beats Q3 2026 forecasts but stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOXzR1cUdFSFR1ZHkwNHN2NFpRRFg1T2pUUHhDVlZDOXk5dk55anBjbkFQSFNQRGxVald4XzhZWlhrU2JrSTNkVHdkeWxqeFRKOFo2cU9mLTdxZTJMZ1J1Y3RLaDBuMlRjTnRBYlNNaWhrRG5iNGdwTUVNMUN4Q0IwODI0MmN3WWZKNmRZZGdlWlF6d1hEajI5Yk9PSXJKQV9lbUQtNGVoNkl4WE4tNDR0bm0yOW9SeDBvRHBqQVFfem0ySkVG?oc=5", "source_name": "Investing.com", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Neogen (NEOG) Now Offering Value After Its Strong Year To Date Share Price Gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNem5ONVhUQUVLUzJCZUJJMzdKQkVJSzM4SmtmbE9IVi1kWk82YTRYa3FvdlhiLVVWdHlpQkFxaFF0SjU0dFhPZTlZd2RmY0U5cF9zWENQRWFucDI1V1dkQkt0cnNRZHhnTllPdjNZMTVJLWRKLVE3MWVnRDFFQTktMVlzaGJIR0R0cXNmZFJ4SW1Bby1aZXBncmk5MA?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Countdown to Neogen (NEOG) Q3 Earnings: Wall Street Forecasts for Key Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONWFqT195Z2hlYlMtcHVQMXQyRVlGcEZPT2FyVkI2dlkwMlJYS0RBN1NfVk1OZzlCOThfZnJJWGZPdmJUYTVycWdkSmxwcG1SZzd2YVkzSWVCcDdhcjZXSi1MUWZoMXRnbEFDUlVFbWxWUlBvZ3lKY1psZ1Q4cWhaSXlCZzZSbFpqci1pNmlBVDMyeWJXaGlWQnhkd0RwWms?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPWmJzLW8xX1VPTE02d1d2bnRTR3JDd29OQzR3a3RtSGExcFdSOVZhRS1SZWZBVThLR2RTTFRaMkhQU1Y2bEc0NHRmSk1ENDdoaWNXNmtRTVhyUVZLU09uZ3E0dGZ6TC1uUnFjeWg1cVZkazVNcTFGQ0QzRkVKbzZLc2EwTGR1RzlGM1k2VFpmVERYb3Y4NDZaMU9rNDU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Neogen Labor Rally Sparks Investor Uncertainty In Michigan", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSFRacHNGRndPYXFUMGlPbzdxbzh1R3hYcnJqVnBNMGtRaE5IUDNUd2ZWa3ZHWUtMdzFuRG1ab0lRVkh0X3ZuWHpSZE5lb01acU9NcFdQU0w2WTBJN3ZRTmVzZFpqcVI4bmg1SVhtRXdJQ2tVMk0ydm1DY2MtOGhobFUyY2tIcWM4YWJOSHc0ei1odFRiZDNN?oc=5", "source_name": "Evrim A\u011fac\u0131", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zoetis to acquire animal genomics business from Neogen", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPSC1OckJCdXpBclZwcGlDeTRtQVRGUDNuNEtPdk1ob2FQTnFoTkVndi1kdWFvdlZxOHdaOFRkb0djQkVYNW9BSGtaMzBGX21xT0tiWkJ3T0dOT2J1NVpqc2U5TmlxZmtJV2hPZTh5UkR6TmRnSnd3c0RDVkJwczdWUUQ5YzRseDVyWUh6Zkl1ekhmV1otTTNkZ0tMVERjbUJxQmxPWWRB?oc=5", "source_name": "Pet Food Processing", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zoetis stock slips despite deal for Neogen genomics unit, BofA and Leerink React", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQOWRrNDdmcUFKcTYxT19OaGU0cHRlU09sT0hqUGloQThoZ1I3Rnp2eDE0NU5aNlFiUzlrMEhqZzVlbFVNcmxhblNzWEo2N2dFOUVHcHlkV21kc2JGUkFzOWFHYkl3UjR5c2NieDRCVTdEQkcyamNFM1p6VUpBUUdOcC0weEwwMW9QQTJFTEpUem1FQXBJZGR4ZmtVVkJzSi0xTFl3NlJTT3lMcnZaQUhFMTljR05DSkNLalpYSzNYbkpaYlJSN3FmQlZ6dXd0ZTdBUENoS0t4cEc?oc=5", "source_name": "Investing.com", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 107, "total_relevant": 66, "sentiment_summary": {"positive": 16, "negative": 8, "neutral": 42, "score": 54, "total": 66, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 15.2, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 14.44, "count": 29}, {"event": "deals", "label": "Deals and strategy", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 16, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 9.62, "latest_week": "2026-07-10", "one_week_move": 3.0, "four_week_move": 5.7, "twelve_week_move": 1.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.187823, "market_dynamics_buy_signal": false, "relative_strength": 6.575329, "fair_value_gap": -20.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.7188, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.0% over one week, +5.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 16}, {"label": "Stock Titan", "count": 7}, {"label": "TradingKey", "count": 6}, {"label": "AD HOC NEWS", "count": 5}, {"label": "simplywall.st", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "MarketBeat", "count": 2}, {"label": "TradingView", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 55}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 29}, {"label": "Market update", "count": 27}, {"label": "Deals and strategy", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "55", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.0% over one week, +5.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Neogen (NASDAQ:NEOG) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?"}], "updated_at": "2026-07-16T14:30:27.802757+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}